IPTACOPAN, Placebo 0 mg hard gelatin capsule size 0, (placebo to LNP023)
CLNP023R12201
Phase 2 small_molecule active
Quick answer
IPTACOPAN, Placebo 0 mg hard gelatin capsule size 0, (placebo to LNP023) for active antineutrophilic cytoplasmic antibody (ANCA) associated vasculitis is a Phase 2 program (small_molecule) at Novartis Ophthalmics Europe with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Ophthalmics Europe
- Indication
- active antineutrophilic cytoplasmic antibody (ANCA) associated vasculitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active